SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer

NCT03066947 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Breastcancer
Breast Neoplasm

Interventions

BIOLOGICAL: SV-BR-1-GM
DRUG: Cyclophosphamide
BIOLOGICAL: Interferon-alpha-2b

Sponsor

BriaCell Therapeutics Corporation

Collaborators

[object Object]